Harout Semerjian
Chief Executive Officer at GLYCOMIMETICS, INC.
Net worth: 6 775 $ as of 31/05/2024
Harout Semerjian active positions
| Companies | Position | Start | End |
|---|---|---|---|
| GLYCOMIMETICS, INC. | Director/Board Member | 06/08/2021 | - |
| Chief Executive Officer | 06/08/2021 | - | |
| President | 06/08/2021 | - | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Director/Board Member | 01/10/2023 | - |
Career history of Harout Semerjian
Former positions of Harout Semerjian
| Companies | Position | Start | End |
|---|---|---|---|
| IMMUNOMEDICS, INC. | Director/Board Member | 16/04/2020 | 27/05/2020 |
| Chief Executive Officer | 16/04/2020 | 27/05/2020 | |
| President | 16/04/2020 | 27/05/2020 | |
Ipsen Pharma SAS
 Ipsen Pharma SAS Pharmaceuticals: MajorHealth Technology Ipsen Pharma SAS is a biopharmaceutical company that develops medicines in oncology, neuroscience and rare diseases. The company was founded by Henri Beaufour in 1929 and is headquartered in Boulogne-Billancourt, France. | Corporate Officer/Principal | 01/03/2018 | 30/04/2020 |
| IPSEN | Corporate Officer/Principal | 01/03/2018 | 01/04/2020 |
Training of Harout Semerjian
| Cornell University | Masters Business Admin |
| Queen's University | Masters Business Admin |
| Lebanese American University | Undergraduate Degree |
Statistics
International
| United States | 5 |
| France | 3 |
| Canada | 2 |
Operational
| Director/Board Member | 3 |
| Corporate Officer/Principal | 2 |
| Chief Executive Officer | 2 |
Sectoral
| Health Technology | 5 |
| Consumer Services | 4 |
| Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| IPSEN | Health Technology |
| GLYCOMIMETICS, INC. | Health Technology |
| Private companies | 3 |
|---|---|
Ipsen Pharma SAS
Ipsen Pharma SAS Pharmaceuticals: MajorHealth Technology Ipsen Pharma SAS is a biopharmaceutical company that develops medicines in oncology, neuroscience and rare diseases. The company was founded by Henri Beaufour in 1929 and is headquartered in Boulogne-Billancourt, France. | Health Technology |
Immunomedics, Inc.
 Immunomedics, Inc. BiotechnologyHealth Technology Immunomedics, Inc. researching, developing, manufacturing, and marketing biopharmaceutical products. It focuses on monoclonal antibody-based products for the targeted treatment of cancer. The company was founded by David M. Goldenberg in July 1982 and is headquartered in Morris Plains, NJ. | Health Technology |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Commercial Services |
- Stock Market
- Insiders
- Harout Semerjian
- Experience
